What the long-term data actually says

Families researching treatment run into the same number within about ten minutes: something in the region of eighty percent success. It comes up on program websites, in admissions calls, and in conversations with people who mean well. The number is real. It comes from a specific study of a specific population under specific conditions, and almost nobody who repeats it says which. Here is what the research actually supports, with the caveats attached, because a statistic without its conditions is not evidence. It is marketing.

Where the eighty percent comes from

The source is a 2008 cohort study in The BMJ by McLellan, Skipper, Campbell and DuPont, following 904 physicians enrolled in state physician health programs. Of the 802 with known outcomes, 647 (80.7 percent) completed treatment and resumed practice under supervision and monitoring. Of those, 523 (81 percent) had no substance use detected across the full five years of monitoring. At five years, 631 of 802 (78.7 percent) were licensed and working (McLellan et al., 2008).

Now the conditions, which matter more than the headline.

These were physicians. The intervention was not a thirty-day admission. It was residential or intensive treatment followed by five years of structured monitoring: random testing, mandated mutual-help attendance, workplace supervision, a case manager who did not go away, and a medical license contingent on all of it. It is one of the most intensive continuing-care packages ever studied.

So the honest reading is not that treatment succeeds eighty percent of the time. It is that a five-year monitored continuing-care package, delivered to motivated professionals with a career at stake, produced outcomes far better than the ones most people are quoted. What the study demonstrates is the value of duration and accountability. It is not a general population success rate, and any program that presents it as one is doing something you should notice.

What the twelve-step evidence supports

The other figure that circulates loosely is the effectiveness of twelve-step involvement. The strongest evidence here is the 2020 Cochrane review by Kelly, Abry, Ferri and Humphreys, covering Alcoholics Anonymous and manualized twelve-step facilitation for alcohol use disorder.

The finding: manualized AA/TSF outperformed comparison treatments on continuous abstinence, with a relative risk of 1.21 (95 percent CI 1.03 to 1.42) at twelve-month follow-up, and advantages sustained at longer follow-up points. In Project MATCH, 24 percent of outpatients assigned to twelve-step facilitation were continuously abstinent through the first year, against 15 percent for cognitive behavioural therapy and 14 percent for motivational enhancement therapy (Kelly et al., distilled in Alcohol and Alcoholism, 2020).

That is a genuine, replicated, peer-reviewed advantage, and Cochrane also found AA/TSF typically achieved it at lower cost. It is also, plainly, a 24 percent figure and not an 80 percent one. Both things are true. A family deserves to hear both.

Duration is the variable that keeps showing up

Across otherwise dissimilar studies, the finding that persists is that time in structured engagement predicts outcome. The National Institute on Drug Abuse states it as a core principle of effective treatment: remaining in treatment for an adequate period is critical, most people need at least three months to meaningfully reduce or stop use, and the best outcomes come with longer durations (NIDA, Principles of Drug Addiction Treatment).

Duration is also where stability appears to consolidate. Dennis, Foss and Scott followed 1,162 people entering treatment over eight years with better than 94 percent follow-up retention, and found that the probability of sustaining abstinence in the coming year rises substantially with the length of abstinence already achieved (Evaluation Review, 2007). Building on that work and on Vaillant’s long-term alcoholism cohorts, a 2015 paper in the Journal of Substance Abuse Treatment argued for five years as the standard for assessing whether treatment worked, on the grounds that by that point relapse risk approaches that of the general population (Five-Year Recovery).

Note what that implies about a thirty-day program measured at discharge. It is measuring the first two percent of the relevant window.

The number families rarely hear

One more, because the data cuts both ways and this side of it gets quoted far less often. A 2017 national survey published in Drug and Alcohol Dependence estimated that 9.1 percent of US adults, roughly 22.35 million people, have resolved a significant substance use problem (Kelly, Bergman, Hoeppner, Vilsaint and White, 2017).

Resolution is common. It is also, in the data, rarely fast and rarely linear.

What we take from all of this

We are not a treatment program and we do not make outcome claims. What the literature changes about how we work is straightforward.

It says the length and continuity of support matter more than the intensity of any single episode. It says the accountability structure, someone whose attention does not end at a discharge date, is doing a large share of the work in the studies with the best results. It says that a plan measured in years is a different object from a plan measured in weeks, and that families should ask what happens in month four before they ask about the amenities.

When somebody quotes you a success rate, ask three questions. Which study. Which population. Measured at what point after discharge. If the answers are not immediate, you have learned something useful anyway.

For what an engagement looks like in practice, see how we help. If you are weighing programs right now, Choosing a treatment center covers the questions worth asking on the tour.

Sources

• McLellan AT, Skipper GS, Campbell M, DuPont RL. Five year outcomes in a cohort study of physicians treated for substance use disorders in the United States. The BMJ, 2008;337:a2038. pmc.ncbi.nlm.nih.gov/articles/PMC2590904
• Kelly JF, Abry A, Ferri M, Humphreys K. Alcoholics Anonymous and 12-Step Facilitation Treatments for Alcohol Use Disorder: A Distillation of a 2020 Cochrane Review. Alcohol and Alcoholism, 2020;55(6):641-651. academic.oup.com/alcalc/article/55/6/641/5867689
• National Institute on Drug Abuse. Principles of Drug Addiction Treatment: A Research-Based Guide, Third Edition. podat-3rdEd-508.pdf
• Dennis ML, Foss MA, Scott CK. An eight-year perspective on the relationship between the duration of abstinence and other aspects of recovery. Evaluation Review, 2007;31(6):585-612. pubmed.ncbi.nlm.nih.gov/17986709
• Five-Year Recovery: A New Standard for Assessing Effectiveness of Substance Use Disorder Treatment. Journal of Substance Abuse Treatment, 2015. jsatjournal.com
• Kelly JF, Bergman BG, Hoeppner BB, Vilsaint CL, White WL. Prevalence and pathways of recovery from drug and alcohol problems in the United States population. Drug and Alcohol Dependence, 2017;181:162-169. recoveryanswers.org